Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Malnutrition 1Liver Neoplasms 1Liver Failure 1Hyperinsulinism 1Fibrosis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Standard of Care 4Enteral Nutrition 4Diet Therapy 4fish oil triglycerides 2alanylglutamine 2Probiotics 2Parenteral Nutrition 2Octreotide 2Nutrition Assessment 2Glutamine 2Dietary Supplements 2Arginine 2phosphatidyltransferase, Clostridium butyricum 1maltodextrin 1Vitamins 1Sampling Studies 1Peptide Hydrolases 1Parenteral Nutrition Solutions 1Nutritional Status 1Nutrition Therapy 1Mirtazapine 1Leucine 1Gemcitabine 1Dronabinol 1Docosahexaenoic Acids 1Dexamethasone 1Control Groups 1Chemotherapy, Adjuvant 1Carnitine 1Carbohydrates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malnutrition × Amino Acids × Gastrointestinal × Clear all
NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡